MCL coexpression mm9:461
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:51506964..51506968,- | p@chr11:51506964..51506968 - |
Mm9::chr14:56373291..56373319,- | p@chr14:56373291..56373319 - |
Mm9::chr2:90758551..90758599,- | p4@Ptpmt1 |
Mm9::chr3:88949993..88949997,+ | p@chr3:88949993..88949997 + |
Mm9::chr4:49554145..49554167,- | p@chr4:49554145..49554167 - |
Mm9::chr9:46037034..46037063,+ | p3@Apoa1 |
Mm9::chr9:46037245..46037274,+ | p@chr9:46037245..46037274 + |
Mm9::chr9:46037284..46037329,+ | p@chr9:46037284..46037329 + |
Mm9::chr9:46037905..46037991,+ | p@chr9:46037905..46037991 + |
Mm9::chr9:46037992..46038069,+ | p@chr9:46037992..46038069 + |
Mm9::chr9:46038084..46038105,+ | p@chr9:46038084..46038105 + |
Mm9::chr9:46038124..46038147,+ | p@chr9:46038124..46038147 + |
Mm9::chr9:46038168..46038182,+ | p@chr9:46038168..46038182 + |
Mm9::chr9:46038285..46038313,+ | p@chr9:46038285..46038313 + |
Mm9::chr9:46038315..46038326,+ | p@chr9:46038315..46038326 + |
Mm9::chr9:46038334..46038346,+ | p@chr9:46038334..46038346 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006644 | phospholipid metabolic process | 0.0100646322602822 |
GO:0006643 | membrane lipid metabolic process | 0.0100646322602822 |
GO:0008035 | high-density lipoprotein binding | 0.0100646322602822 |
GO:0043534 | blood vessel endothelial cell migration | 0.0100646322602822 |
GO:0006066 | alcohol metabolic process | 0.0100646322602822 |
GO:0030300 | regulation of cholesterol absorption | 0.0100646322602822 |
GO:0033344 | cholesterol efflux | 0.0100646322602822 |
GO:0030299 | cholesterol absorption | 0.0100646322602822 |
GO:0051346 | negative regulation of hydrolase activity | 0.0100646322602822 |
GO:0044241 | lipid digestion | 0.0100646322602822 |
GO:0004332 | fructose-bisphosphate aldolase activity | 0.0100646322602822 |
GO:0004439 | phosphoinositide 5-phosphatase activity | 0.0100646322602822 |
GO:0017127 | cholesterol transporter activity | 0.0104993479606997 |
GO:0043542 | endothelial cell migration | 0.0104993479606997 |
GO:0016832 | aldehyde-lyase activity | 0.0104993479606997 |
GO:0015248 | sterol transporter activity | 0.0104993479606997 |
GO:0001935 | endothelial cell proliferation | 0.0104993479606997 |
GO:0050892 | intestinal absorption | 0.0104993479606997 |
GO:0008211 | glucocorticoid metabolic process | 0.0104993479606997 |
GO:0030325 | adrenal gland development | 0.0104993479606997 |
GO:0019915 | sequestering of lipid | 0.0104993479606997 |
GO:0046488 | phosphatidylinositol metabolic process | 0.0104993479606997 |
GO:0042577 | lipid phosphatase activity | 0.0104993479606997 |
GO:0022600 | digestive system process | 0.0125187001789079 |
GO:0008034 | lipoprotein binding | 0.0125187001789079 |
GO:0044255 | cellular lipid metabolic process | 0.0125187001789079 |
GO:0030301 | cholesterol transport | 0.0125187001789079 |
GO:0015918 | sterol transport | 0.012933152358935 |
GO:0006629 | lipid metabolic process | 0.0151075883712702 |
GO:0006695 | cholesterol biosynthetic process | 0.0176972577212691 |
GO:0016126 | sterol biosynthetic process | 0.0225670200839581 |
GO:0004437 | inositol or phosphatidylinositol phosphatase activity | 0.0226144161912928 |
GO:0006793 | phosphorus metabolic process | 0.0231003898986493 |
GO:0006796 | phosphate metabolic process | 0.0231003898986493 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 0.0241154328663319 |
GO:0016830 | carbon-carbon lyase activity | 0.0253987668275815 |
GO:0007586 | digestion | 0.0253987668275815 |
GO:0030384 | phosphoinositide metabolic process | 0.0253987668275815 |
GO:0006096 | glycolysis | 0.0253987668275815 |
GO:0005319 | lipid transporter activity | 0.0253987668275815 |
GO:0042158 | lipoprotein biosynthetic process | 0.0253987668275815 |
GO:0043086 | negative regulation of catalytic activity | 0.0253987668275815 |
GO:0035270 | endocrine system development | 0.0253987668275815 |
GO:0033238 | regulation of amine metabolic process | 0.0253987668275815 |
GO:0001932 | regulation of protein amino acid phosphorylation | 0.0253987668275815 |
GO:0006521 | regulation of amino acid metabolic process | 0.0253987668275815 |
GO:0006007 | glucose catabolic process | 0.0253987668275815 |
GO:0046365 | monosaccharide catabolic process | 0.0253987668275815 |
GO:0019320 | hexose catabolic process | 0.0253987668275815 |
GO:0042325 | regulation of phosphorylation | 0.0253987668275815 |
GO:0051174 | regulation of phosphorus metabolic process | 0.0253987668275815 |
GO:0046164 | alcohol catabolic process | 0.0253987668275815 |
GO:0019220 | regulation of phosphate metabolic process | 0.0253987668275815 |
GO:0042157 | lipoprotein metabolic process | 0.0253987668275815 |
GO:0006650 | glycerophospholipid metabolic process | 0.0253987668275815 |
GO:0008203 | cholesterol metabolic process | 0.0275166999907174 |
GO:0044275 | cellular carbohydrate catabolic process | 0.0278757035020892 |
GO:0006694 | steroid biosynthetic process | 0.0286356062966939 |
GO:0016125 | sterol metabolic process | 0.0287214385786459 |
GO:0016052 | carbohydrate catabolic process | 0.0287214385786459 |
GO:0006869 | lipid transport | 0.0287214385786459 |
GO:0048732 | gland development | 0.0287214385786459 |
GO:0042445 | hormone metabolic process | 0.0306269909533715 |
GO:0043687 | post-translational protein modification | 0.0306269909533715 |
GO:0004725 | protein tyrosine phosphatase activity | 0.0318174451233092 |
GO:0051347 | positive regulation of transferase activity | 0.0324231184672487 |
GO:0006006 | glucose metabolic process | 0.0347948497498764 |
GO:0006470 | protein amino acid dephosphorylation | 0.0373990372565175 |
GO:0006464 | protein modification process | 0.0373990372565175 |
GO:0051336 | regulation of hydrolase activity | 0.0373990372565175 |
GO:0043412 | biopolymer modification | 0.0391151911267399 |
GO:0016311 | dephosphorylation | 0.0393429465131948 |
GO:0019318 | hexose metabolic process | 0.0426022080885103 |
GO:0043085 | positive regulation of catalytic activity | 0.0426022080885103 |
GO:0005996 | monosaccharide metabolic process | 0.0426022080885103 |
GO:0051338 | regulation of transferase activity | 0.0426022080885103 |
GO:0008202 | steroid metabolic process | 0.0435943265602065 |
GO:0004721 | phosphoprotein phosphatase activity | 0.0442552835622009 |
GO:0016829 | lyase activity | 0.0456561661233562 |
GO:0043170 | macromolecule metabolic process | 0.0456561661233562 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |